RFX6 Regulates Insulin Secretion by Modulating Ca<sup>2+</sup>Homeostasis in Human β Cells
Chandra V., Albagli-Curiel O., Hastoy B., Piccand J., Randriamampita C., Vaillant E., Cavé H., Busiah K., Froguel P., Vaxillaire M., Rorsman P., Polak M., Scharfmann R.
© 2014 The Authors. Development and function of pancreatic β cells involve the regulated activity of specific transcription factors. RFX6 is a transcription factor essential for mouse β cell differentiation that is mutated in monogenic forms of neonatal diabetes. However, the expression and functional roles of RFX6 in human β cells, especially in pathophysiological conditions, are poorly explored. We demonstrate the presence of RFX6 in adult human pancreatic endocrine cells. Using the recently developed human β cell line EndoC-βH2, we show that RFX6 regulates insulin gene transcription, insulin content, and secretion. Knockdown of RFX6 causes downregulation of Ca 2+ -channel genes resulting in the reduction in L-type Ca 2+ -channel activity that leads to suppression of depolarization-evoked insulin exocytosis. We also describe a previously unreported homozygous missense RFX6 mutation (p.V506G) that is associated with neonatal diabetes, which lacks the capacity to activate the insulin promoter and to increase Ca 2+ -channel expression. Our data therefore provide insights for understanding certain forms of neonatal diabetes.